Parents Rejoice As An EpiPen Competitor Becomes Available at Much Lower Cost

Advertisement
Read next

Advertisement

screen-shot-2016-10-26-at-3-04-27-pm

Allergic reactions are no joke, and it doesn’t help that Mylan’s EpiPen has spiked the price by 400 percent. Fortunately, privately held drugmaker Kaleo announced Wednesday plans for a U.S. relaunch of its epinephrine auto-injector in early 2017. EpiPen’s rival, Auvi-Q, will be reintroduced at a “very, very low” cost to patients, said Kaleo CEO Spencer Williamson.

Auvi-Q contains the same epinephrine as Mylan NV’s EpiPen, but was recalled from the market last year amid concerns about the accuracy of the dosage delivered. Kaleo says they have fixed this issue.

Are you thankful for this alternative? Let us know in the comments below!

 

Welcome to our Tinybeans family!
Be sure to check your email for new activities, recipes and parenting hacks – and to see if you’ve won!

 

 

 

 

 

 

Spring Giveaway: Enter to Win a $500 Gift Card!

Enter your email and zip code below for a chance to win a Mastercard Gift Card. We’ll pick one winner per month through August 31, 2022 – 5 lucky winners in all!

I agree to the official rules and I agree to receive email communications from Tinybeans. By providing your email address, you agree to our Privacy Policy and Terms of Service